Discovering restorative, novel therapeutics for patients with life altering neurodegenerative diseases and developmental disorders.

Biotechnology

Synaptogenix

Alan Tuchman

Daniel L. Alkon

Elaine Grenier

Robert Weinstein

The Scientific Advisory Team at Synaptogenix provides expert guidance on research and development strategies, evaluates emerging scientific data, and ensures the scientific integrity of the company's efforts to discover novel therapeutics for neurodegenerative diseases and developmental disorders.

Scientific Advisory Team

About

Team members

Other teams at Synaptogenix

Leadership Team